Supplementary Tables 1-6 from Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor–Initiating Cells

Supplementary Tables 1-6. Supplementary Table 1: Clinico-pathological demographics of CD133high and CD133low GBM; Supplementary Table 2: Positive and negative correlation probe sets present in CD133-signature; Supplementary Table 3: Drug targets acquired from CD133 gene signature connectivity map; Supplementary Table 4: qRT-PCR Primers; Supplementary Table 5: Genes used to complete network analysis; Supplementary Table 6: Molecular Subtypes of GBM samples used